Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models

Mohamed Ahmed, Sonya VanPatten, Satyanarayana Lakshminrusimha, Hardik Patel, Thomas R. Coleman, Yousef Al-Abed

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Pulmonary hypertension (PH) is a complex disease comprising a pathologic remodeling and thickening of the pulmonary vessels causing an after load on the right heart ventricle that can result in ventricular failure. Triggered by oxidative stress, episodes of hypoxia, and other undetermined causes, PH is associated with poor outcomes and a high rate of morbidity. In the neonate, this disease has a similar etiology but is further complicated by the transition to breathing after birth, which requires a reduction in vascular resistance. Persistent pulmonary hypertension of the newborn (PPHN) is one form of PH that is frequently unresponsive to current therapies including inhaled nitric oxide (due to lack of proper absorption and diffusion), and other therapeutics targeting signaling mediators in vascular endothelium and smooth muscle. The need for novel agents, which target distinct pathways in pulmonary hypertension, remains. Herein, we investigated the therapeutic effects of novel muscarinic receptor ligand C1213 in models of PH. We demonstrated that via M3 muscarinic receptors, C1213 induced activating- eNOS phosphorylation (serine-1177), which is known to lead to nitric oxide (NO) production in endothelial cells. Using signaling pathway inhibitors, we discovered that AKT and calcium signaling contributed to eNOS phosphorylation induced by C1213. As expected for an eNOS-stimulating agent, in ex vivo and in vivo models, C1213 triggered pulmonary vasodilation and induced both pulmonary artery and systemic blood pressure reductions demonstrating its potential value in PH and PPHN. In brief, this proof-of-concept study provides evidence that an M3 muscarinic receptor functionally selective ligand stimulates downstream pathways leading to antihypertensive effects using in vitro, ex vivo, and in vivo models of PH.

Original languageEnglish (US)
Article numbere13069
JournalPhysiological Reports
Volume4
Issue number24
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Keywords

  • C1213
  • Muscarinic receptor
  • Nitric oxide
  • PPHN
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Effects of novel muscarinic M3 receptor ligand C1213 in pulmonary arterial hypertension models'. Together they form a unique fingerprint.

  • Cite this